Christian K Kollmannsberger

Christian K Kollmannsberger

UNVERIFIED PROFILE

Are you Christian K Kollmannsberger?   Register this Author

Register author
Christian K Kollmannsberger

Christian K Kollmannsberger

Publications by authors named "Christian K Kollmannsberger"

Are you Christian K Kollmannsberger?   Register this Author

37Publications

1158Reads

40Profile Views

Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.

Clin Genitourin Cancer 2020 Jan 8. Epub 2020 Jan 8.

Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, BC Cancer, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.12.018DOI Listing
January 2020

Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe.

J Clin Oncol 2019 08 10;37(22):1856-1862. Epub 2019 Jun 10.

2Testicular Cancer Commons, Vancouver, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00502DOI Listing
August 2019

Current Management of Disseminated Germ Cell Tumors.

Urol Clin North Am 2019 Aug 21;46(3):377-388. Epub 2019 May 21.

Division of Medical Oncology, Department of Medicine, BC Cancer--Vancouver Cancer Center, University of British Columbia, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2019.04.003DOI Listing
August 2019

Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial.

Eur Urol 2019 06 24;75(6):940-947. Epub 2018 Dec 24.

Department of Medical Oncology, BC Cancer Vancouver Centre, Vancouver, BC, Canada; Department of Urological Sciences, The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183102
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.12.015DOI Listing
June 2019

Clinical effectiveness of docetaxel for castration-sensitive prostate cancer in a real-world population-based analysis.

Prostate 2019 02 28;79(3):281-287. Epub 2018 Oct 28.

Division of Medical Oncology, University of British Columbia, BC Cancer, Vancouver, British Columbia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pros.23733
Publisher Site
http://dx.doi.org/10.1002/pros.23733DOI Listing
February 2019

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

N Engl J Med 2018 Apr 21;378(14):1277-1290. Epub 2018 Mar 21.

From Memorial Sloan Kettering Cancer Center, New York (R.J.M.), and Roswell Park Cancer Institute, Buffalo (S.G.) - both in New York; University of Texas M.D. Anderson Cancer Center, Houston (N.M.T., P. Sharma); Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center (D.F.M.), and Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School (T.K.C.), Boston; Centro Internacional de Estudios Clínicos (O.A.F.) and Fundación Arturo López Pérez (P. Salman), Santiago, Chile; Palacký University and University Hospital Olomouc, Olomouc, Czech Republic (B.M.); Fox Chase Cancer Center, Philadelphia (E.R.P.); Hôpitaux Universitaires de Strasbourg, Strasbourg (P.B.), Bordeaux University Hospital, Hôpital Saint-André, Bordeaux (A.R.), and Institut Gustave Roussy, Villejuif (B.E.) - all in France; Istituto di Ricovero e Cura a Carattere Scientifico San Matteo University Hospital Foundation, Pavia (C.P.), and Ospedale San Donato, Azienda Unità Sanitaria Locale Toscana Sud-Est, Istituto Toscano Tumori, Arezzo (S.B.) - both in Italy; Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free NHS Trust (T.P.), and Cancer Research UK (R.H.), London; Aarhus University Hospital, Aarhus, Denmark (F.D.); Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv - both in Israel (V.N.); British Columbia Cancer Agency, Vancouver, Canada (C.K.K.); Westmead Hospital and Macquarie University, Sydney (H.G.); Jena University Hospital, Jena, Germany (M.-O.G.); Centro de Pesquisa em Oncologia, Hospital São Lucas, Porto Alegre, Brazil (C.H.B.); Niigata University, Niigata, Japan (Y.T.); Hospital Universitario 12 de Octubre, Madrid (D.C.); Cleveland Clinic Taussig Cancer Institute, Cleveland (B.I.R.); Bristol-Myers Squibb, Princeton, NJ (A.C.C., S.M., M.B.M., M.W.-R., J.D.); and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (H.J.H.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1712126
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1712126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972549PMC
April 2018

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.

J Clin Oncol 2017 11 30;35(31):3525-3528. Epub 2017 Aug 30.

Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Christian K. Kollmannsberger, University of British Columbia, Vancouver, British Columbia, Canada; Bruce J. Roth, Washington University School of Medicine, St Louis, MO; Claudio Jeldres, Sherbrooke University, Sherbrooke, Quebec, Canada; Silke Gillessen, Kantonsspital, St Gallen, Switzerland; Karim Fizazi, University of Paris Sud, Paris, France; Siamak Daneshmand, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA; William T. Lowrance, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Nasser H. Hanna, Indiana University School of Medicine, Indianapolis, IN; Gabriella Cohn Cedermark, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden; Darren R. Feldman, Memorial Sloan Kettering Cancer Center and Weill Medical Cornell Medical College, New York, NY; Thomas Powles, Barts Cancer Institute, St Bartholomew's Hospital, Queen Mary University of London, London, United Kingdom; Mark A. Lewis, Intermountain Health, Salt Lake City, UT; Peter Scott Grimison, University of Sydney, Sydney, New South Wales, Australia; Douglas Bank, Testicular Cancer Resource Center, Riverwoods, IL; Christopher Porter, Virginia Mason Medical Center, Seattle, WA; Peter Albers, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany; Maria De Santis, Cancer Research Center, University of Warwick, Coventry, United Kingdom; Sandy Srinivas, Stanford University School of Medicine, Stanford, CA; George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Craig R. Nichols, Precision Genomics Cancer Research Clinic, Intermountain Health, Salt Lake City, UT; Testicular Cancer Commons, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.4723DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791831PMC
November 2017

New treatments for stage I testicular cancer.

Clin Adv Hematol Oncol 2017 Aug;15(8):626-631

Division of Medical Oncology, University of British Columbia, British Columbia, Canada.

View Article

Download full-text PDF

Source
August 2017

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

J Clin Oncol 2017 Apr 27;35(11):1211-1222. Epub 2017 Feb 27.

Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women's Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Robert J. Hamilton, Princess Margaret Cancer Center, Toronto, Ontario; Christian K. Kollmannsberger, University of British Columbia, Vancouver, British Columbia, Canada; David J. Vaughn, University of Pennsylvania, Philadelphia, PA; Steve E. Lipshultz, Wayne State University School of Medicine; Steve E. Lipshultz, Children's Hospital of Michigan; Steve E. Lipshultz, Karmanos Cancer Institute, Detroit, MI; and Sophie D. Fossa, Oslo University Hospital, Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455601PMC
April 2017

Reply to L.C. Pagliaro et al.

J Clin Oncol 2015 Jul 1;33(20):2328. Epub 2015 Jun 1.

Virginia Mason Medical Center, Section of Hematology/Oncology, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.4842DOI Listing
July 2015

Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinoma.

J Oncol Pract 2013 Sep 4;9(5):e262-7. Epub 2013 Jun 4.

Queen Elizabeth II Health Sciences Centre; Victoria General Hospital, Dalhousie University, Halifax, Nova Scotia; Sunnybrook Health Sciences Centre; St Michael's Hospital; Princess Margaret Hospital, University of Toronto, Toronto; University of Ottawa, Ottawa; St Joseph's Hospital, McMaster University, Hamilton, Ontario; Vancouver Prostate Centre, University of British Columbia; Vancouver Cancer Centre, University of British Columbia, Vancouver, British Columbia; Tom Baker Cancer Centre, Calgary; University of Alberta; Cross Cancer Institute, University of Alberta, Edmonton, Alberta; Centre Hospitalier de L'Université de Montreal, University of Montreal; and Montreal General Hospital, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2012.000870DOI Listing
September 2013